Cargando…
Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network
BACKGROUND: There is increasing evidence that opioid analgesics may interfere with tumour growth. It is currently thought that these effects are mediated by transactivation of receptor tyrosine kinase (RTK)-controlled ERK1/2 and Akt signalling. The growth of many breast cancer cells is dependent on...
Autores principales: | Weingaertner, Inka Regine, Koutnik, Sarah, Ammer, Hermann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538590/ https://www.ncbi.nlm.nih.gov/pubmed/23308242 http://dx.doi.org/10.1371/journal.pone.0053510 |
Ejemplares similares
-
Correction: Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network
por: Weingaertner, Inka Regine, et al.
Publicado: (2016) -
Correction: Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network
por: Weingaertner, Inka Regine, et al.
Publicado: (2015) -
Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells
por: Akbari, Azam, et al.
Publicado: (2020) -
Voltage-gated K(+) channels promote BT-474 breast cancer cell migration
por: Chow, Louis WC, et al.
Publicado: (2018) -
Design and Characterization of Liposomal Methotrexate and Its Effect on BT-474 Breast Cancer Cell Line
por: Tavakoli Dastjerd, Niloufar, et al.
Publicado: (2021)